HELISAV-B

Shares of Dynavax Technologies Corporation (NASDAQ: DVAX) surged by 20 percent Monday after the clinical-stage bio pharmaceutical company released a regulatory filing. In its filing, Dynavax said it received from the U.S. Food and Drug Administration a request for information concerning its...